JPH0225906B2 - - Google Patents

Info

Publication number
JPH0225906B2
JPH0225906B2 JP61118001A JP11800186A JPH0225906B2 JP H0225906 B2 JPH0225906 B2 JP H0225906B2 JP 61118001 A JP61118001 A JP 61118001A JP 11800186 A JP11800186 A JP 11800186A JP H0225906 B2 JPH0225906 B2 JP H0225906B2
Authority
JP
Japan
Prior art keywords
group
sub
lower alkyl
pyridine
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61118001A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6253966A (ja
Inventor
Mutsuji Mori
Nobuhiro Ooi
Yoshuki Oosugi
Yasuhiro Yamashita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of JPS6253966A publication Critical patent/JPS6253966A/ja
Publication of JPH0225906B2 publication Critical patent/JPH0225906B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP61118001A 1985-05-23 1986-05-22 新規ピリジン誘導体 Granted JPS6253966A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11064285 1985-05-23
JP60-110642 1985-05-23

Publications (2)

Publication Number Publication Date
JPS6253966A JPS6253966A (ja) 1987-03-09
JPH0225906B2 true JPH0225906B2 (index.php) 1990-06-06

Family

ID=14540880

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61118001A Granted JPS6253966A (ja) 1985-05-23 1986-05-22 新規ピリジン誘導体

Country Status (14)

Country Link
US (1) US4691018A (index.php)
EP (1) EP0203435B1 (index.php)
JP (1) JPS6253966A (index.php)
KR (1) KR860008980A (index.php)
CN (1) CN86103501A (index.php)
AT (1) ATE55992T1 (index.php)
AU (1) AU587251B2 (index.php)
CA (1) CA1240332A (index.php)
DE (1) DE3673693D1 (index.php)
ES (1) ES8707934A1 (index.php)
HU (1) HU195486B (index.php)
SU (1) SU1419517A3 (index.php)
YU (1) YU83686A (index.php)
ZA (1) ZA863706B (index.php)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877795A (en) * 1987-01-30 1989-10-31 Kissei Pharmaceutical Co., Ltd. 4H-quinolizin-4-one compounds useful for the treatment of allergic bronchial asthma, allergic rhinitis atropic dermatitis and the like
DE3703963A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen
US4904657A (en) * 1987-09-24 1990-02-27 Kissei Pharmaceutical Co., Ltd. 4H-quinolizin-4-one compounds exhibiting therapeutic activities
JP2746832B2 (ja) * 1993-05-14 1998-05-06 大鵬薬品工業株式会社 眼局所抗アレルギー剤
TW264385B (index.php) * 1993-05-14 1995-12-01 Taiho Pharmaceutical Co Ltd
WO2010141883A1 (en) * 2009-06-04 2010-12-09 The Regents Of The University Of Colorado Compounds that modulate autoimmunity and methods of using the same
US9629848B2 (en) 2011-05-26 2017-04-25 The Regents Of The University Of Colorado, A Body Corporate Compounds that modulate autoimmunity and methods of using the same
MX361955B (es) 2012-08-30 2018-12-19 Huntleigh Technology Ltd Sistema con sabana protectora multicapa de apoyo para pacientes.
EP3247384B1 (en) 2015-01-14 2023-10-04 The Regents of the University of Colorado, a body corporate In vitro method of diagnosis of type 1 diabetes with insulin mimotopes
US9820957B2 (en) 2016-03-24 2017-11-21 The Regents Of The University Of Colorado, A Body Corporate Methods of treating autoimmunity
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0057797B1 (en) * 1981-02-03 1986-06-25 Imperial Chemical Industries Plc Process for the extraction of metal values and novel metal extractants
JPS58105920A (ja) * 1981-12-17 1983-06-24 Chugai Pharmaceut Co Ltd 抗癌剤
JPS58159465A (ja) * 1982-03-17 1983-09-21 Chugai Pharmaceut Co Ltd ピリジン誘導体

Also Published As

Publication number Publication date
CA1240332A (en) 1988-08-09
AU5726786A (en) 1986-11-27
YU83686A (en) 1988-06-30
EP0203435B1 (en) 1990-08-29
ZA863706B (en) 1987-01-28
HU195486B (en) 1988-05-30
KR860008980A (ko) 1986-12-19
JPS6253966A (ja) 1987-03-09
DE3673693D1 (de) 1990-10-04
SU1419517A3 (ru) 1988-08-23
EP0203435A2 (en) 1986-12-03
AU587251B2 (en) 1989-08-10
CN86103501A (zh) 1987-01-21
HUT41735A (en) 1987-05-28
ES555240A0 (es) 1987-09-01
ES8707934A1 (es) 1987-09-01
US4691018A (en) 1987-09-01
ATE55992T1 (de) 1990-09-15
EP0203435A3 (en) 1988-01-07

Similar Documents

Publication Publication Date Title
FI64159C (fi) Foerfarande foer framstaellning av oralt effektiva antiallergiska 11-oxo-11-h-pyrido(2,1-b)-kinazoliner
JPH11500406A (ja) アセトアミド誘導体類及び食作用挙動モディファイアー
JPH0225906B2 (index.php)
NO154426B (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive trans-3-(4-okso-4h-kinazolin-3-yl)-2-propensyrederivater.
SU1195903A3 (ru) Способ получени 1-фенил- 2-аминокарбонилиндольных соединений или их солей присоединени кислот
JPWO1992002514A1 (ja) 新規なベンゾピラン誘導体
US4036964A (en) Isocarbostyril-3-carboxylic acid derivatives for the prophylaxis of asthma, hayfever and rhinitis
JP3083842B2 (ja) 新規かつ強力な最終分化誘発剤及びその使用方法
US4125625A (en) Troponyl-oxamic acid derivatives
US4066784A (en) Tropone derivatives
CA1244435A (en) Pyrazolo¬1,5-a|pyridine derivatives and compositions containing them
JPS6399057A (ja) グリシン誘導体
US3975535A (en) Anti-allergic-3-carboxy-isocoumarin compositions and methods of use
US4183943A (en) Organic compounds
NO781051L (no) Kinazolinderivater.
JPS6136754B2 (index.php)
US4183955A (en) Troponyl-oxamic acid derivatives for treating allergic conditions
JP2006513250A (ja) アラニン系化合物、その製造方法及び用途
JPH03294277A (ja) ピペリジン誘導体
KR820000496B1 (ko) 퀴나졸린 유도체의 제조방법
US3468889A (en) O-and/or s-nicotinoyl diacylthiamines and acylation process for preparing the same
US4221814A (en) Terephthalic acid monoamide derivatives, process for preparing the same, and an anti-allergic agent prepared from the same
JPS61109770A (ja) ２位置にα‐ヒドロキシル鎖が置換した４‐ヒドロキシ‐３‐キノリンカルボン酸より誘導される新エステル、その製造、薬剤としての使用及びそれを含む組成物
KR0147887B1 (ko) 4-티오퀴놀린 유도체
JPS61233678A (ja) ベンジルピペラジン誘導体